Open database of authors and journals




Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension

Journal of Heart and Lung Transplantation, 2020, 39, 1389-1397

Michele D'Alto, Roberto Badagliacca, Francesco Lo Giudice, Paola Argiento, Gavino Casu, Marco Corda, Michele Correale, Stefano Ghio, Alessandra Greco, Mariangela Lattanzio, Valentina Mercurio, Giuseppe Paciocco, Silvia Papa, Renato Prediletto, Emanuele Romeo, Maria Giovanna Russo, Alessandro Tayar, Patrizio Vitulo, Carmine Dario Vizza, Paolo Golino, Robert Naeije

Citation of paper, Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
G16272.2
C11558,0277.8

Journals Citing This Paper

JournalCiting PapersJournal's IFJournal's Star
Journal of Clinical Medicine14.9

Similar Articles

2015

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

New England Journal of Medicine (56.8 1183★★★), 373, 834-44.
2021

Recent advances in the management of pulmonary arterial hypertension: lessons from the upfront combination of ambrisentan and tadalafil

2016

Ambrisentan (Letairis) and tadalafil (Adcirca) for pulmonary arterial hypertension

2018

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension

2014

Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension

Hypertension Research (4.5 94), 37, 507-12.
2011

Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension

American Journal of Cardiology (2.9 292), 108, 302-7.
2005

Ambrisentan for pulmonary arterial hypertension

Future Cardiology (1.2 37), 1, 425-32.
Quick Tips
This is an overview of where and by who this paper has been cited.
Help Us
Non-profit projects normally ask for donations. We don't. We will survive one way or another. If you wish to help us, please spread the word to let more people use this service.

It is delightful to see our efforts are useful to a broad range of researchers.
EXALY
Authors
Journals
Institutions
Fields